MedPage Today on MSN1dOpinion
Precision Medicine for Prostate Cancer
Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...
A new study has revealed that men who don't heed recommendations for prostate cancer screenings are at a significantly higher ...
New research shows the risk of prostate cancer increases by 45 percent in men who share one common practice. According to the ...
On one side, are over 12,000 men every year in the UK who have their lives cut short by prostate cancer. Families are ...
A campaign has been launched to encourage more men to check their prostate cancer risks. According to Barnsley Metropolitan Borough Council, prostate cancer has been the most commonly diagnosed ...
A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
Prostate cancer is the most common cancer in men. Figures published in 2021 by Public Health Scotland state 4265 men were ...
Diagnostic biopsy is essential for risk stratification, treatment planning, and prognostication of prostate cancer. Incorporation of multiparametric MRI in the evaluation of men with no prior ...
The study collects information from seven European ... are at a significantly higher risk of dying from prostate cancer compared to men who were not offered screening or accepted an invitation ...
Research reveals men skipping prostate cancer screenings are 45% ... The study collects information from seven European nations — Finland, the Netherlands, Italy, Sweden, Switzerland, Belgium ...